BioBlue Technologies, a global corporation providing world-class technologies focused on regenerative medicines, pharmaceuticals and Blue technologies which improves the overall healthy lifespan of our consumers.
We have a diversified technology portfolio aimed at maximizing revenue. Our blue technology is a process which combines a gas that is generated by hyper-exciting water clusters and a liquid made by electromagnetically charging silica, used to improve the body’s ability to heal. This technology will also be used in industrial and agricultural applications. Our regenerative technologies involve propriety stem cell therapies and regenerative treatments used to treat a variety of diseases and improve the quality of life. The combination of our two technologies is used to produce dramatic improvements to new and existing pharmaceuticals, cosmeceuticals and nutraceuticals.
CHIP VanVurst, Chief Executive Officer and BioBlue Board Chairman. Henry’s the visionary of BioBlue Technologies, and has run a variety of businesses over the past three decades...
Andrew VanVurst, Chief Operating Officer and BioBlue Board Member.At the age of 14, he entered Florida Atlantic University; at the age of 19, he joined the Marine Corps where he trained...
Jason Matuszewski is Chief Financial Officer of BioBlue, and is also a Director and Co-Founder. He began his engineering career at the age of 15 working as a data analysis engineer...
POMPANO BEACH, FL–(Marketwired – Jun 9, 2017) – BioStem Technologies, Inc. (OTC PINK: BSEM) (“BSEM” or “the company”), a global corporation providing world-class solutions focused on Regenerative Medicines, Pharmaceuticals and Blue Technologies, is eager to announce that its Oakland Park, Florida based subsidiary, BioBlue Technologies Inc. (“BioBlue”), has signed a Letter of Intent (“LOI”) with […]Read More
OAKLAND PARK, FL–(Marketwired – Apr 6, 2017) – BioStem Technologies Inc. (OTC PINK: BSEM) (“BioStem Tech” or the “Company”), an emerging International Biotechnology company, engaged D. Brooks and Associates CPA’s, P.A. as their PCAOB registered certified public auditing firm. As BSEM transitions out of the start-up phase and into the growth stage, the corporate team […]Read More
POMPANO BEACH, FL–(Marketwired – Mar 27, 2017) – BioStem Technologies, Inc. (OTC PINK: BSEM) (“BSEM” or “the company”), an emerging International Biotechnology company, is eager to announce that its Oakland Park, Florida-based subsidiary, Qualified Pharma Ingredients Inc. (“QPI”), has been granted their Prescription Drug Repackager permit from the Florida Department of Business & Professional Regulation. […]Read More
OAKLAND PARK, FL–(Marketwired – Mar 24, 2017) – BioStem Technologies, Inc. (OTC PINK: BSEM) (“BSEM” or “the company”), an emerging International BioTech company, celebrated the opening of its new laboratory and corporate offices with a ribbon cutting ceremony hosted by the BioStem Technologies executive team. BSEM’s Founder and CEO, Henry Van Vurst, commented, “With the […]Read More